Canagliflozin is a Selective SGLT2 Inhibitor for Metabolic Disease Research
In healthy individuals, nearly all the glucose filtered at the glomerulus is reabsorbed, and no glucose is found in the urine. However, when glucose in plasma exceeds a threshold level,…